Physician profile
William P Conners, III
NPI 1154588531
$11,939.26
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,385 · 2020: $3,886 · 2021: $668.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,319.72 | 2019-2021 | |
| Antares Pharma, INC. | $3,401.00 | 2019-2021 | |
| Aytu Biopharma, INC. | $2,019.24 | 2019-2020 | |
| Astellas Pharma US INC | $416.34 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $293.38 | 2019-2021 | |
| Allergan, INC. | $247.37 | 2019-2021 | |
| Pfizer INC. | $180.57 | 2019-2021 | |
| Janssen Biotech, INC. | $155.64 | 2019 | |
| Neotract INC. | $129.07 | 2019-2020 | |
| Metuchen Pharmaceuticals | $123.49 | 2019 | |
| Zyla Life Sciences, INC. | $122.73 | 2019 | |
| Abbvie INC. | $84.13 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $82.76 | 2019-2021 | |
| Blue Earth Diagnostics | $60.50 | 2019-2021 | |
| 180 Medical, INC. | $58.86 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $40.15 | 2020 | |
| Myriad Genetic Laboratories, INC. | $29.18 | 2021 | |
| Myovant Sciences INC. | $27.55 | 2021 | |
| Axonics, INC. | $26.59 | 2021 | |
| Boston Scientific Corporation | $24.08 | 2019-2020 | |
| Foundation Medicine, INC. | $21.96 | 2021 | |
| Merck Sharp & Dohme LLC | $20.81 | 2021 | |
| Hollister Incorporated | $15.62 | 2019 | |
| Clarus Therapeutics INC. | $14.06 | 2021 | |
| Hologic Sales and Service, LLC | $13.36 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Conners listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.